{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:21Z","timestamp":1793308881925,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijbiomac.2020.04.191","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T02:18:03Z","timestamp":1588126683000},"page":"159-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria"],"prefix":"10.1016","volume":"158","author":[{"given":"Manisha","family":"Pritam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchit","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satarudra Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0005","unstructured":"World Malaria Report 2019. Geneva: World Health Organization. www.who.int\/malaria\/publications\/world-malaria-report-2019, 2019 (Accessed 16 December 2019)."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0010","unstructured":"World Malaria Report 2018. Geneva: World Health Organization. www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/, 2018 (Accessed 4 February 2019)."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1458","article-title":"Challenges and strategies for developing efficacious and long-lasting malaria vaccines","volume":"11","author":"Beeson","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(03)15267-1","article-title":"Malaria vaccine developments","volume":"363","author":"Moorthy","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0030","doi-asserted-by":"crossref","first-page":"40169","DOI":"10.1074\/jbc.M509631200","article-title":"Distinct protein classes including novel merozoite surface antigens in raft-like membranes of Plasmodium falciparum","volume":"280","author":"Sanders","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pctr.0020012","article-title":"Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria","volume":"2","author":"Malkin","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(03)00536-X","article-title":"Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children","volume":"22","author":"Genton","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0045","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/515331","article-title":"Phase I\/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"177","author":"Ockenhouse","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0055","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/infdis\/jit385","article-title":"Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans","volume":"208","author":"Patel","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0065","first-page":"987","article-title":"Antigenic diversity and immune evasion by malaria parasites","volume":"11","author":"Ferreira","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1473-3099(18)30344-X","article-title":"Safety and immunogenicity of Pfs25H-EPA\/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults","volume":"18","author":"Sagara","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1277-x","article-title":"Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure","volume":"17","author":"Kurtovic","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.01617","article-title":"Immune escape strategies of malaria parasites","volume":"7","author":"Gomes","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4236\/aid.2016.62011","article-title":"Immune evasion by Plasmodium falciparum parasites: converting a host protection mechanism for the parasite\u2019s benefit","volume":"6","author":"Dinko","year":"2016","journal-title":"Adv. Infectious Diseases"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6529681","article-title":"Immune response and evasion mechanisms of Plasmodium falciparum parasites","volume":"2018","author":"Belachew","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0095","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0100","first-page":"4","article-title":"Listeria-review of epidemiology and pathogenesis","volume":"40","author":"Ramaswamy","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humimm.2009.11.009","article-title":"Computational characterization of Plasmodium falciparum proteomic data for screening of potential vaccine candidates","volume":"71","author":"Singh","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0110","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","article-title":"Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum","volume":"120","author":"Vakili","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12859-018-2482-x","article-title":"Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum","volume":"19","author":"Pritam","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0130","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1002\/jcb.27110","article-title":"Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection","volume":"119","author":"Pandey","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","article-title":"Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach","volume":"7","author":"Khatoon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39299-8","article-title":"Designing a multi-epitope based vaccine to combat Kaposi sarcoma utilizing immunoinformatics approach","volume":"9","author":"Chauhan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-2713-9","article-title":"PanRV: Pangenome-reverse vaccinology approach for identifications of potential vaccine candidates in microbial pangenome","volume":"20","author":"Naz","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0155","doi-asserted-by":"crossref","unstructured":"A. Rahmani, M. Baee, M. Rostamtabar, A. Karkhah, S. Alizadeh, M. Tourani, H.R. Nouri, Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches, Int. J. Biol. Macromol., 141(2019) 125\u2013136. doi.org\/https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.08.259.","DOI":"10.1016\/j.ijbiomac.2019.08.259"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijbiomac.2019.07.024","article-title":"Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach","volume":"138","author":"Kalita","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0165","doi-asserted-by":"crossref","first-page":"13069","DOI":"10.1021\/acsomega.9b00944","article-title":"Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection","volume":"4","author":"Ojha","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0170","article-title":"Immunoinformatics-guided designing of peptide vaccine against Lassa virus with dynamic and immune simulation studies","author":"Sayed","year":"2019","journal-title":"Preprints"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0175","first-page":"1","article-title":"Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen Elizabethkingia anophelis using immunoinformatic approaches","author":"Nain","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micpath.2019.02.023","article-title":"Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus","volume":"130","author":"Hasan","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nri1978","article-title":"Protozoan encounters with toll-like receptor signalling pathways: implications for host parasitism","volume":"6","author":"Gazzinelli","year":"2006","journal-title":"Nat. Rev.Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.exppara.2011.03.010","article-title":"Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2\/TLR1","volume":"128","author":"Zhu","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0200","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1111\/febs.12541","article-title":"Structure and dynamic behavior of toll-like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum","volume":"280","author":"Durai","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0205","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J Immsunol"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0210","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","article-title":"In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations","volume":"11","author":"Yang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1552-9","article-title":"A novel multi-epitope recombined protein for diagnosis of human brucellosis","volume":"16","author":"Yin","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","article-title":"Immunoinformatics analysis and in silico designing of a novel multiepitope peptide vaccine against Staphylococcus aureus","volume":"48","author":"Hajighahramani","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","article-title":"A novel design of a multi-antigenic, multistage and multi-epitope vaccine against helicobacter pylori: an in silico approach","volume":"49","author":"Meza","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0230","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4049\/jimmunol.0803737","article-title":"Mapping of a microbial protein domain involved in binding and activation of the TLR2\/TLR1 heterodimer","volume":"182","author":"Liang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/jpet.110.173765","article-title":"A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-\u03b1 release from mouse JAWS II dendritic cells","volume":"336","author":"Awasthi","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0240","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.vaccine.2017.12.001","article-title":"Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine","volume":"36","author":"Kaba","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0245","doi-asserted-by":"crossref","unstructured":"K. Ahmadi, G. Pouladfar, M. Kalani, S. Faezi, M.R. Pourmand, S. Hasanzadeh, L. Mafakher, M.M. Aslani, M. Mahdavi, Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: induction of multi-pattern immune responses, Mol. Immunol.. 114(2019) 88\u201399. doi.org\/https:\/\/doi.org\/10.1016\/j.molimm.2019.05.016.","DOI":"10.1016\/j.molimm.2019.05.016"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103704","article-title":"Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach","volume":"136","author":"Singh","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0260","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/352595a0","article-title":"Common west African HLA antigens are associated with protection from severe malaria","volume":"352","author":"Hill","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4269\/ajtmh.2008.78.251","article-title":"HLA-DRB1*04 allele is associated with severe malaria in northern Ghana","volume":"78","author":"Osafo-Addo","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0036419","article-title":"Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3\u03b1 and MSP-9 in individuals from Brazilian endemic area","volume":"7","author":"Lima-Junior","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0275","first-page":"223","article-title":"HLA-A alleles differentially associate with severity to Plasmodium falciparum malaria infection in Ibadan, Nigeria","volume":"20","author":"Ademola","year":"2017","journal-title":"Afr. J. Biomed. Res."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0280","doi-asserted-by":"crossref","unstructured":"G. Triller, S.W. Scally, G. Costa, M. Pissarev, C. Kreschel, A. Bosch, E. Marois, B.K. Sack, R. Murugan, A.M. Salman, C.J. Janse, S.M. Khan, S. Kappe, A.A. Adegnika, B. Mordm\u00fcller, E.A. Levashina, J.P. Julien, H. Wardemann, Natural parasite exposure induces protective human anti-malarial antibodies, Immunity. 47(2017), 1197\u20131209.e10. doi.org\/https:\/\/doi.org\/10.1016\/j.immuni.2017.11.007.","DOI":"10.1016\/j.immuni.2017.11.007"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0285","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0290","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"Lopez-Blanco","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0295","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/aem.56.1.202-209.1990","article-title":"Identification of the minimal replicon of Lactococcus lactis subsp. lactis UC317 plasmid pCI305","volume":"56","author":"Hayes","year":"1990","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000095","article-title":"The US Food and Drug Administration provides a pathway for licensing vaccines for global diseases","volume":"6","author":"Brennan","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0305","first-page":"25","article-title":"RTS,S malaria vaccine development: progress and considerations for postapproval introduction","volume":"6","author":"Asante","year":"2016","journal-title":"Vaccine: Development and Therapy"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0310","first-page":"1","article-title":"Safety profile of the RTS,S\/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa","volume":"23","author":"Guerra Mendoza","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0315","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0320","doi-asserted-by":"crossref","first-page":"3.1.1","DOI":"10.1002\/0471250953.bi0301s42","article-title":"An introduction to sequence similarity (\u201chomology\u201d) searching","volume":"42","author":"Pearson","year":"2013","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.meegid.2018.03.007","article-title":"Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection","volume":"61","author":"Narula","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0330","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","article-title":"In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases","volume":"9","author":"Shey","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0335","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0340","series-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/v11010063","article-title":"Exploring the Papillomaviral proteome to identify potential candidates for a chimeric vaccine against cervix papilloma using immunomics and computational structural vaccinology","volume":"11","author":"Kaliamurthi","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0350","first-page":"1145","article-title":"Cytokines in the pathogenesis of and protection against malaria","volume":"9","author":"Angulo","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2017.00324","article-title":"Cytokines and chemokines in cerebral malaria pathogenesis","volume":"7","author":"Dunst","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0360","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.171.12.6961","article-title":"Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma","volume":"171","author":"Sun","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-11-109","article-title":"Changes in the levels of cytokines, chemokines and malaria-specific antibodies in response to Plasmodium falciparum infection in children living in sympatry in Mali","volume":"11","author":"Bostrom","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01329","article-title":"The development of Plasmodium falciparum-specific IL10 CD4 T cells and protection from malaria in children in an area of high malaria transmission","volume":"8","author":"Boyle","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6760830","article-title":"An introduction to B-cell epitope mapping and in silico epitope prediction","volume":"2016","author":"Potocnakova","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0380","first-page":"4866","article-title":"Oral immunization with rotavirus VP7-CTB fusion expressed in transgenic Arabidopsis thaliana induces antigen-specific IgA and IgG and passive protection in mice","volume":"15","author":"Li","year":"2018","journal-title":"Exp. Therapeutic Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0385","doi-asserted-by":"crossref","unstructured":"X. Li, Y. Xing, L. Guo, X. Lv, H. Song, T. Xi, Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates helicobacter pylori infection in mice, Pathogens and disease. 72(2014) 78\u201386. doi.org\/https:\/\/doi.org\/10.1111\/2049-632X.12173.","DOI":"10.1111\/2049-632X.12173"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0390","doi-asserted-by":"crossref","unstructured":"H. Lei, X. Peng, H. Jiao, D. Zhao, J. Ouyang, Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice, Microb. Cell Factories. 14(2015) 1\u201310. doi.org\/https:\/\/doi.org\/10.1186\/s12934-015-0287-4.","DOI":"10.1186\/s12934-015-0287-4"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0395","doi-asserted-by":"crossref","unstructured":"J. Hou, Y. Liu, J. Hsi, H. Wang, R. Tao, Y. Shao, Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice, Human Vaccines & Immunotherapeutics. 10(2014) 1274\u20131283. doi.org\/https:\/\/doi.org\/10.4161\/hv.28371.","DOI":"10.4161\/hv.28371"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0400","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.meegid.2017.09.015","article-title":"Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach","volume":"55","author":"Vishnu","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0410","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mehy.2019.01.006","article-title":"PRE-binding protein of Plasmodium falciparum is a potential candidate for vaccine design and development: an in silico evaluation of the hypothesis","volume":"125","author":"Sanasam","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0420","doi-asserted-by":"crossref","unstructured":"A.I. Khan, M.S. Islam, M.T. Islam, A. Ahmed, M.I. Chowdhury, F. Chowdhury, M. Siddik, J.D. Clemens, F. Qadri, Oral cholera vaccination strategy: self-administration of the second dose in urban Dhaka, Bangladesh, Vaccine. 37(2019) 827\u2013832. doi.org\/https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.048.","DOI":"10.1016\/j.vaccine.2018.12.048"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0425","doi-asserted-by":"crossref","first-page":"107259","DOI":"10.1016\/j.compbiolchem.2020.107259","article-title":"Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: a contemporary approach","volume":"86","author":"Singh","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0430","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines3030579","article-title":"Cholera toxin subunit B as adjuvant\u2013\u2013an accelerator in protective immunity and a break in autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0435","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/ijmm.2015.2146","article-title":"Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes","volume":"35","author":"Yao","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0440","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.2144\/Oct0208","article-title":"Toll-like receptor signaling and regulation of cytokine gene expression in the immune system","volume":"33","author":"Ozato","year":"2002","journal-title":"BioTechniques"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0445","doi-asserted-by":"crossref","unstructured":"B.S. Franklin, P. Parroche, M.A. Ata\u00edde, F. Lauw, C. Ropert, R.B. de Oliveira, D. Pereira, M.S. Tada, P. Nogueira, L.H. da Silva, H. Bjorkbacka, D.T. Golenbock, R.T. Gazzinelli, Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function, Proc. Natl. Acad. Sci. U. S. A.. 106(2009) 5789\u20135794. doi.org\/https:\/\/doi.org\/10.1073\/pnas.0809742106.","DOI":"10.1073\/pnas.0809742106"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","article-title":"TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review","volume":"20","author":"Mukherjee","year":"2016","journal-title":"Brazilian J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0455","doi-asserted-by":"crossref","unstructured":"E.J. Pone, H. Zan, J. Zhang, A. Al-Qahtani, Z. Xu, P. Casali, Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses, Crit. Rev. Immunol.. 30(2010) 1\u201329. doi.org\/https:\/\/doi.org\/10.1615\/critrevimmunol.v30.i1.10.","DOI":"10.1615\/CritRevImmunol.v30.i1.10"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/243713","article-title":"Interferons and interferon regulatory factors in malaria","volume":"2014","author":"Gun","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41496-4","article-title":"Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa","volume":"9","author":"Solanki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0470","doi-asserted-by":"crossref","unstructured":"M.T. Orr, E.A. Beebe, T.E. Hudson, J.J. Moon, C.B. Fox, S.G. Reed, R.N. Coler, 2014. A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. PLoS One. 9, e83884. doi.org\/https:\/\/doi.org\/10.1371\/journal.pone.0083884.","DOI":"10.1371\/journal.pone.0083884"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","article-title":"A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice","volume":"209","author":"Vakili","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0480","doi-asserted-by":"crossref","unstructured":"E.G. Reed-Geaghan, J.C. Savage, A.G. Hise, G.E. Landreth, CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation, J. Neurosci.. 29(2009) 11982\u201311992. doi.org\/https:\/\/doi.org\/10.1523\/JNEUROSCI.3158-09.2009.","DOI":"10.1523\/JNEUROSCI.3158-09.2009"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0485","doi-asserted-by":"crossref","unstructured":"J.M. Billod, A. Lacetera, J. Guzm\u00e1n-Caldentey, S. Mart\u00edn-Santamar\u00eda, Computational approaches to toll-like receptor 4 modulation, Molecules (Basel, Switzerland). 21(2016) 1\u201324. doi.org\/https:\/\/doi.org\/10.3390\/molecules21080994.","DOI":"10.3390\/molecules21080994"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.04.191_bb0490","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0495","first-page":"1","article-title":"The emerging role of pattern recognition receptors in the pathogenesis of malaria","volume":"6","author":"Kalantari","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0500","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijpddr.2018.10.006","article-title":"The toll-like receptor 2 agonist PEG-pam(2)Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites","volume":"8","author":"Ernest","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0505","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.vaccine.2013.01.041","article-title":"Modulation of HIV peptide antigen specific cellular immune response by synthetic \u03b1-and \u03b2-defensin peptides","volume":"31","author":"Mohan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0510","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.celrep.2014.03.018","article-title":"Interferon-mediated innate immune responses against malaria parasite liver stages","volume":"7","author":"Miller","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0515","doi-asserted-by":"crossref","unstructured":"A. Tandon, M. Pathak, M.K. Harioudh, S. Ahmad, M. Sayeed, T. Afshan, M.I. Siddiqi, K. Mitra, S.M. Bhattacharya, J.K. Ghosh, A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice, J. Biol. Chem.. 293(2018) 19874\u201319885. doi.org\/https:\/\/doi.org\/10.1074\/jbc.RA118.002768.","DOI":"10.1074\/jbc.RA118.002768"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0520","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0525","article-title":"Physicochemical properties of particulate vaccine adjuvants: their pivotal role in modulating immune responses","author":"Bastola","year":"2018","journal-title":"J. Pharm. Res. Investigation"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0530","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/jsbi.2001.4336","article-title":"Review: protein secondary structure prediction continues to rise","volume":"134","author":"Rost","year":"2001","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0535","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi, psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0540","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biochi.2013.09.013","article-title":"A protein structural classes prediction method based on predicted secondary structure and PSI-BLAST profile","volume":"97","author":"Ding","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines6010001","article-title":"Structural analysis and epitope prediction of MHC class-1-chain related protein-a for cancer vaccine development","volume":"6","author":"Adekiya","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0550","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20\u00a0years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0555","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0560","doi-asserted-by":"crossref","unstructured":"L.G. Berm\u00fadez-Humar\u00e1n, P. Kharrat, J.M. Chatel, P. Langella, Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines, Microb. Cell Factories. 10(2011) 1\u201310. doi.org\/https:\/\/doi.org\/10.1186\/1475-2859-10-S1-S4.","DOI":"10.1186\/1475-2859-10-S1-S4"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0565","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Miquel-Clop\u00e9s","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CVI.00533-16","article-title":"Cytokine profiles in Malawian children presenting with uncomplicated malaria, severe malarial anemia, and cerebral malaria","volume":"24","author":"Mandala","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0575","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/504720","article-title":"Clusters of cytokines determine malaria severity in Plasmodium falciparum infected patients from endemic areas of Central India","volume":"194","author":"Prakash","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12639-013-0237-1","article-title":"Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha","volume":"38","author":"Sarangi","year":"2014","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0585","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0048304","article-title":"Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine","volume":"7","author":"Kaba","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","article-title":"Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design","volume":"112","author":"Kazi","year":"2018","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0600","doi-asserted-by":"crossref","unstructured":"A. Mubarak, W. Alturaiki, M.G. Hemida, Middle East respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development, J Immunol Res. 2019(2019) 1\u201311. doi.org\/https:\/\/doi.org\/10.1155\/2019\/6491738.","DOI":"10.1155\/2019\/6491738"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0605","doi-asserted-by":"crossref","unstructured":"A.S. Mustafa, In silico analysis and experimental validation of Mycobacterium tuberculosis -specific proteins and peptides of Mycobacterium tuberculosis for immunological diagnosis and vaccine development, Medical Principles and Practice. 22(2013) 43\u201351. doi.org\/https:\/\/doi.org\/10.1159\/000354206.","DOI":"10.1159\/000354206"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0615","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0620","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01796-17","article-title":"A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques","volume":"92","author":"Jones","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0625","doi-asserted-by":"crossref","unstructured":"E. Chen, D. Urusova, N.D. Salinas, F. Ntumngia, L. Carias, Y. Huang, J. Adhikari, S.J. Barnes, M.L. Gross, C.L. King, J.H. Adams JN.H. Tolia, Structural vaccinology for malaria: host\u2013pathogen interactions, broadly neutralizing antibodies and immunogen design, Acta Cryst. A74(2018). doi.org\/https:\/\/doi.org\/10.1107\/S01087673180983.","DOI":"10.1107\/S0108767318098392"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0630","doi-asserted-by":"crossref","unstructured":"B.E. Correia, J.T. Bates, R.J. Loomis, G. Baneyx, C. Carrico, J.G. Jardine, R. Rupert, C. Correnti, O. Kalyuzhniy, V. Vittal, M.J. Connell, E. Stevens, A. Schroeter, M. Chen, S. Macpherson, A.M. Serra, Y. Adachi, M.A. Holmes, Y. Li, R.E. Klevit, B.S. Graham, R.T. Wyatt, D. Baker, R.K. Strong, J.E. Crowe Jr., P.R. Johnson, W.R. Schief. Proof of principle for epitope-focused vaccine design, Nature. 507(2014) 201\u2013206. doi.org\/https:\/\/doi.org\/10.1038\/nature12966.","DOI":"10.1038\/nature12966"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0635","doi-asserted-by":"crossref","unstructured":"I. Sela-Culang, Y. Ofran, B. Peters, Antibody specific epitope prediction-emergence of a new paradigm, Curr. Opin. Virology. 11(2015) 98\u2013102. doi.org\/https:\/\/doi.org\/10.1016\/j.coviro.2015.03.012.","DOI":"10.1016\/j.coviro.2015.03.012"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0640","doi-asserted-by":"crossref","unstructured":"R. Rappuoli, M.J. Bottomley, U. D'Oro, O. Finco, E. De Gregorio, Reverse vaccinology 2.0: human immunology instructs vaccine antigen design, J. Exp. Med.. 213(2016) 469\u2013481. doi.org\/https:\/\/doi.org\/10.1084\/jem.20151960.","DOI":"10.1084\/jem.20151960"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v10040197","article-title":"The hard way towards an antibody-based HIV-1 Env vaccine: lessons from other viruses","volume":"10","author":"Ringel","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0650","first-page":"363","article-title":"Malaria transmission-blocking vaccines: present status and future perspectives, towards malaria elimination - a leap forward, Sylvie Manguin and vas dev","volume":"15","author":"Doumbo","year":"2018","journal-title":"IntechOpen Chapter"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0655","first-page":"1","article-title":"Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25","volume":"2019","author":"McLeod","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3017-2","article-title":"Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei","volume":"18","author":"Lee","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2953-1","article-title":"Contributions of natural killer cells to the immune response against Plasmodium","volume":"18","author":"Burrack","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0670","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy","volume":"88","author":"Fong","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2680160","article-title":"Fundamentals and methods for T- and B-cell epitope prediction","volume":"2017","author":"Sanchez-Trincado","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0680","doi-asserted-by":"crossref","unstructured":"K. W\u00fcthrich, G. Wagner,R. Richarz, W. Braun, Correlations between internal mobility and stability of globular proteins, Biophys. J.. 32(1980) 549\u2013560. doi.org\/https:\/\/doi.org\/10.1016\/S0006-3495(80)84989-7.","DOI":"10.1016\/S0006-3495(80)84989-7"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2019.103936","article-title":"Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus)","volume":"74","author":"Azim","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0690","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0695","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/cmb.2019.0062","article-title":"Immunoinformatics approach to design a novel epitope-based oral vaccine against helicobacter pylori","volume":"26","author":"Urrutia-Baca","year":"2019","journal-title":"Journal of Computational Biol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0700","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-019-0890-6","article-title":"Codon harmonization reduces amino acid misincorporation in bacterially expressed P. falciparum proteins and improves their immunogenicity","volume":"9","author":"Punde","year":"2019","journal-title":"AMB Express"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0705","first-page":"48","article-title":"Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion","volume":"14","author":"Morello","year":"2008","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0710","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pep.2011.06.005","article-title":"Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems","volume":"79","author":"Pontes","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0715","doi-asserted-by":"crossref","unstructured":"M. Bahey-El-Din, C.G. Gahan, Lactococcus lactis-based vaccines: current status and future perspectives, Human vaccines. 7(2011) 106\u2013109. doi.org\/https:\/\/doi.org\/10.4161\/hv.7.1.13631.","DOI":"10.4161\/hv.7.1.13631"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0720","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-017-1955-0","article-title":"Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48\/45 and Pfs230 proteins increase with age in malaria patients living in the central region of Ghana","volume":"16","author":"Acquah","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-017-0710-0","article-title":"Construct design, production, and characterization of Plasmodium falciparum 48\/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine","volume":"16","author":"Singh","year":"2017","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0730","doi-asserted-by":"crossref","unstructured":"S.K. Singh, R.W. Tiendrebeogo, B.K. Chourasia, I.H. Kana, S. Singh, M. Theisen, Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum, Microb. Cell Factories. 17(2018) 1\u201313. doi.org\/https:\/\/doi.org\/10.1186\/s12934-018-0902-2.","DOI":"10.1186\/s12934-018-0902-2"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0735","doi-asserted-by":"crossref","unstructured":"S.K. Singh, S. Thrane, B.K. Chourasia, K. Teelen, W. Graumans, R. Stoter, G.J. van Gemert, M.G. van de Vegte-Bolmer, M.A. Nielsen, A. Salanti, A.F. Sander, R.W. Sauerwein, M.M. Jore, M. Theisen, Pfs230 and Pfs48\/45 fusion proteins elicit strong transmission-blocking antibody responses against Plasmodium falciparum, Front. Immunol.. 10(2019) 1\u201312. doi.org\/https:\/\/doi.org\/10.3389\/fimmu.2019.01256.","DOI":"10.3389\/fimmu.2019.01256"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0740","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1074\/jbc.RA119.011268","article-title":"The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable","volume":"295","author":"Singh","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0745","doi-asserted-by":"crossref","unstructured":"A. Stedman, M.A. Chambers, J. Gutierrez-Merino, Secretion and functional expression of Mycobacterium bovis antigens MPB70 and MPB83 in lactic acid bacteria, Tuberculosis (Edinburgh, Scotland). 117(2019) 24\u201330. doi.org\/https:\/\/doi.org\/10.1016\/j.tube.2019.05.007.","DOI":"10.1016\/j.tube.2019.05.007"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0750","doi-asserted-by":"crossref","unstructured":"P. Mancha-Agresti, C.P. de Castro, J. Dos Santos, M.A. Araujo, V.B. Pereira, J.G. LeBlanc, S.Y. Leclercq, V. Azevedo, Recombinant invasive Lactococcus lactis carrying a DNA vaccine coding the Ag85A antigen increases INF-\u03b3, IL-6, and TNF-\u03b1 cytokines after intranasal immunization, Front. Microbiol.. 8(2017) 1\u201312. doi.org\/https:\/\/doi.org\/10.3389\/fmicb.2017.01263.","DOI":"10.3389\/fmicb.2017.01263"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0755","article-title":"Expression of helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice","volume":"142","author":"Aliramaei","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0760","doi-asserted-by":"crossref","unstructured":"A.K. Szczepankowska, K. Szatraj, P. Sa\u0142a\u0144ski, A. R\u00f3zga, R.K. G\u00f3recki, J.K. Bardowski, Recombinant Lactococcus lactis expressing Haemagglutinin from a polish avian H5N1 isolate and its immunological effect in preliminary animal trials, Biomed. Res. Int.. 2017(2017) 1\u20138. doi.org\/https:\/\/doi.org\/10.1155\/2017\/6747482.","DOI":"10.1155\/2017\/6747482"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0765","doi-asserted-by":"crossref","unstructured":"X. Zhang, S. Hu, X. Du, T. Li, L. Han, J. Kong, Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development, J. Microbiol. Immunol. Infect.. 49(2016) 851\u2013858. doi.org\/https:\/\/doi.org\/10.1016\/j.jmii.2014.11.009.","DOI":"10.1016\/j.jmii.2014.11.009"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-015-0271-z","article-title":"Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis","volume":"14","author":"Samazan","year":"2015","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0775","doi-asserted-by":"crossref","unstructured":"E. Davarpanah, N. Seyed, F. Bahrami, S. Rafati, R. Safaralizadeh, T. Taheri, 2020. Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB\/c mice. PLoS Negl. Trop. Dis.. 14, e0007939. doi.org\/https:\/\/doi.org\/10.1371\/journal.pntd.0007939.","DOI":"10.1371\/journal.pntd.0007939"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0780","doi-asserted-by":"crossref","unstructured":"A.H. Mohseni, V. Razavilar, H. Keyvani, M.R. Razavi, R.A. Khavari-Nejad, Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL\/6 mice, J. Med. Virol.. 91(2019) 296\u2013307. doi.org\/https:\/\/doi.org\/10.1002\/jmv.25303.","DOI":"10.1002\/jmv.25303"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0785","doi-asserted-by":"crossref","unstructured":"K.Q. Xin, Y. Hoshino, Y. Toda, S. Igimi, Y. Kojima, N. Jounai, K. Ohba, A. Kushiro, M. Kiwaki, K. Hamajima, D. Klinman, K. Okuda, Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV, Env. Blood. 102(2003) 223\u2013228. doi.org\/https:\/\/doi.org\/10.1182\/blood-2003-01-0110.","DOI":"10.1182\/blood-2003-01-0110"},{"key":"10.1016\/j.ijbiomac.2020.04.191_bb0790","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505433","article-title":"Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease","volume":"194","author":"Buccato","year":"2006","journal-title":"J. Infect. Dis."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020330506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020330506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:13:34Z","timestamp":1786569214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020330506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":158,"alternative-id":["S0141813020330506"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.04.191","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.04.191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}